Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Recommendation of “Moderate Buy” by Brokerages
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) has received an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price […]
More Stories
Amprius Technologies (NYSE:AMPX) vs. Ilika (OTCMKTS:ILIKF) Financial Analysis
Amprius Technologies (NYSE:AMPX – Get Free Report) and Ilika (OTCMKTS:ILIKF – Get Free Report) are both industrials companies, but which...
Bluzelle Reaches 24-Hour Trading Volume of $4.13 Million (BLZ)
Bluzelle (BLZ) traded up 0.8% against the dollar during the twenty-four hour period ending at 0:00 AM E.T. on October...
Kyber Network Crystal Legacy Price Tops $0.54 on Major Exchanges (KNCL)
Kyber Network Crystal Legacy (KNCL) traded flat against the U.S. dollar during the 1 day period ending at 0:00 AM...
Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Update
Rockwell Medical, Inc. (NASDAQ:RMTI – Get Free Report) was the target of a large growth in short interest in the...
Ebang International Holdings Inc. (NASDAQ:EBON) Short Interest Up 41.3% in October
Ebang International Holdings Inc. (NASDAQ:EBON – Get Free Report) saw a significant growth in short interest in October. As of...
MTR (OTCMKTS:MTCPY) Stock Price Up 3.7% – Here’s What Happened
MTR Co. Limited (OTCMKTS:MTCPY – Get Free Report) rose 3.7% during mid-day trading on Tuesday . The company traded as...